Clinical Trials Directory

Trials / Conditions / Gray Zone Lymphoma

Gray Zone Lymphoma

10 registered clinical trials studyying Gray Zone Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingAmping up With PemJAK
NCT07283822
Seda S. ToluPhase 2
UnknownAn Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD3
NCT05208853
Zhejiang UniversityEARLY_Phase 1
UnknownA Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymp
NCT04860674
Zhejiang Cancer HospitalPhase 2
RecruitingPolatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Agg
NCT04231877
University of WashingtonPhase 1
Active Not RecruitingStudy of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
NCT03602157
UNC Lineberger Comprehensive Cancer CenterPhase 1
CompletedPembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PC
NCT03255018
National Cancer Institute (NCI)Phase 2
CompletedHaploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
NCT02996773
University of ArizonaPhase 1
CompletedSafety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
NCT01943682
Children's Hospital Medical Center, CincinnatiPhase 1
CompletedMaintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
NCT01665768
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
CompletedDose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lympho
NCT00001337
National Cancer Institute (NCI)Phase 2